Last reviewed · How we verify
NCT04622657
Validity Reliability of The Dubousset Functional Test in Parkinson Disease
NA trial testing dubousset functional test in Parkinson Disease in 30 participants. Completed in 1 April 2022.
1 April 2022
Quick facts
| Lead sponsor | Kırıkkale University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | sequential |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 25 October 2020 |
| Primary completion | 1 April 2022 |
| Estimated completion | 1 April 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- dubousset functional test
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Balance; Distorted — all drugs for Balance; Distorted →
- Fall — all drugs for Fall →
- Gait Disorders, Neurologic — all drugs for Gait Disorders, Neurologic →
Sponsor
Kırıkkale University
Who can join
Adults 40 to 85, any sex, with Parkinson Disease or Balance; Distorted. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In order to achieve collaborative patient-centered rehabilitation in Parkinson's disease, detailed evaluation of walking and balance in evaluating the perceived difficulty in daily life is important to evaluate the progression of the disease and its response to treatments. In the literature, there are many scales that evaluate balance and functional performance in Parkinson Disease. However there is no validity and reliability study of Dubousset Function Test developed to evaluate balance and functional performance of Parkinson Disease. For this reason, the aim of study is to examine the validity and reliability of Dubousset Function Test in Parkinson Disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04622657
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Kırıkkale University trials
Trials by the same sponsor.
- NCT07323420 — Effects of Different Inspiratory:Expiratory Ratios on Respiratory and Recovery Outcomes During Dental Procedures Under G · recruiting
- NCT07504861 — Biomarkers in Apical Periodontitis · not yet recruiting
- NCT07451860 — Chronic Total Occlusion and Triglyceride-Glucose Index · not yet recruiting
- NCT06921369 — The Effect of Compassionate Care Education on Nurses · NA · not yet recruiting
- NCT07338253 — The Effect of the Flipped Learning Model on Spiritual Care Perception and Competence in Nursing Students · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04622657 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kırıkkale University
- Last refreshed: 12 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04622657.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing